首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

2093461

HLA型組織配對檢驗全球市場

Global HLA Typing for Transplant Market

出版日期: 2026年07月10日 | 出版商:

BCC Research | 英文 85 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

本報告分析了全球HLA型組織配對檢驗市場，包括市場規模、成長趨勢、產業趨勢、新興技術和競爭格局。

該市場按產品類型/服務類型、技術、應用、最終用戶和地區進行細分，涵蓋北美、歐洲、亞太地區和世界其他地區。該研究包括對固態器官移植和造血幹細胞移植等關鍵應用的分析，以及對領導企業的概況介紹和至2030年的預測。

調查範圍

全球HLA型組織配對檢驗市場研究範圍包括對市場動態、新興技術、產業結構與市場成長驅動趨勢的詳細檢驗，以及市場規模分析。市場按產品類型、技術、應用、最終用戶和地區進行細分。

本報告概述了全球用於移植的HLA型檢測市場，並分析了市場趨勢。報告包含2024年基準年的全球銷售額（百萬美元）以及2025年至2030年預測期間的預估數據。根據產品類型和服務類型，市場分為設備、耗材和服務。根據技術，市場分為非分子檢測和分子檢測。 HLA型檢測的應用包括固態器官移植和造血幹細胞移植。按最終用戶分類，市場分為醫院和移植中心、診斷檢查室和實驗室。本報告也聚焦於市場的區域分類。本研究涵蓋的地區包括北美、歐洲、亞太地區和世界其他地區，並著重分析了各地區的主要國家。

本報告最後分析了競爭格局，並特別闢出章節介紹公司概況，詳細介紹市場領導者的資訊。

報告內容

全球植入用HLA型檢測市場概況與分析
全球趨勢分析（包括 2024 年銷售數據、2025 年估計值以及到 2030 年的複合年成長率預測）
對全球市場的當前市場規模和收入成長預測進行估算，並按技術、產品類型、應用和最終用戶進行市場佔有率分析。
有關市場動態的事實和數據，包括市場促進因素、市場限制因素和機會。
基於波特五力模型的洞察，以及對影響市場的宏觀經濟因素的分析。
移植中HLA型檢測型監管環境概述。
針對HLA型檢測。
競爭資訊包括產業結構、企業市場占有率分析和策略發展。
全球攜帶式HLA型檢測市場主要公司概覽

細分市場
產品類型/服務細分：全球HLA型檢測市場（用於移植）
消耗品
裝置
服務
全球HLA型檢測市場按技術分類的便攜性
Molecular Technologies
非分子技術
全球HLA型檢測市場按應用領域分類的便攜性
固態器官移植
幹細胞移植
全球HLA型檢測市場以最終用戶進行移植
醫院及移植中心
診斷檢查室
研究機構
按地區分類
區域細分：全球用於移植的HLA型檢測市場
北美洲
歐洲
亞太地區
世界其他地區（RoW）

第7章競爭情勢

企業市場占有率分析
戰略分析

第8章附錄

調查方法
簡稱
資訊來源
公司簡介
AGILENT TECHNOLOGIES INC.
BD
BIO-RAD LABORATORIES INC.
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
OXFORD NANOPORE TECHNOLOGIES PLC.
PACBIO
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
A Few Emerging Start-ups/Market Disruptors

簡介目錄圖表

Product Code: BIO277A

This report analyzes the global HLA typing for transplant market, covering market size, growth trends, industry dynamics, emerging technologies, and competitive developments. The market is segmented by product and service type, technology, application, end user, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study includes insights into key applications such as solid organ and hematopoietic stem cell transplants, along with profiles of leading companies and forecasts through 2030.

Report Scope

The scope of the global HLA typing for transplant market study encompasses market size analysis, along with a detailed examination of market dynamics, emerging technologies, industry structure, and trends driving market growth. The market has been segmented based on product type, technology, application, end user, and region.

The report provides an overview of the global HLA typing for transplant market and examines market trends. It includes global revenue ($ million) for the base year 2024 and estimated data for the forecast period 2025 through 2030. Based on product and service type, the market is segmented into instruments, consumables, and services. Based on technology, the market is segmented into nonmolecular and molecular assays. Applications of HLA typing include solid-organ and hematopoietic stem cell transplants. Based on end user, the market is classified into hospitals and transplant centers, diagnostic laboratories, and research institutions. The report also focuses on the regional segmentation of the market. The regions covered in this study include North America, Europe, Asia-Pacific, and the rest of the world, with a focus on major countries in each region.

The report concludes with an analysis of the competitive landscape. It also has a dedicated section of company profiles that covers details of leading key market companies.

Report Includes

An overview and analysis of the global market for HLA typing for transplant
Analyses of global market trends, with revenue data for 2024, estimates for 2025, and projections of CAGRs through 2030
Estimates of the current market size and revenue growth prospects for the global market, along with a market share analysis by technology, product and service type, application and end user
Facts and figures related to market dynamics, including drivers, restraints and opportunities
Insights derived from Porter's Five Forces model and analysis of macroeconomic factors influencing the market
Review of the regulatory landscape affecting HLA typing for transplant
Discussion of emerging technologies, newest technology trends and developments in HLA typing
Competitive intelligence including industry structure, company share analysis and strategic developments
Profiles of leading companies operating in the global HLA typing for transplant market

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion

Chapter 2 Market Overview

Overview
Classification of HLA Systems
HLA Typing in Transplantation
Porter's Five Forces Analysis
Potential of New Entrants (Moderate)
Bargaining Power of Suppliers (Low to Moderate)
Bargaining Power of Buyers (High)
Threat of Substitute Products (Low)
Industry Rivalry (High)
Macroeconomic Factors Analysis
Healthcare Budget Priorities
Geopolitical Factors
Tariffs' Impact on HLA Typing for Transplant Market

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Increasing Demand for Solid Organ Transplants
Growing Prevalence of Blood Cancers
Market Restraints
Demand and Supply Gaps in Organ Donations
High Equipment and Testing Costs
Market Opportunities
Growing Focus on Precision Transplantation Procedures
Expansion of Donor Registries

Chapter 4 Regulatory Landscape

Regulatory Aspects of HLA Typing for Transplant
U.S.
Europe
Asia-Pacific

Chapter 5 Emerging Technologies

Key Takeaways
Emerging Technologies
Next-Generation Sequencing (NGS)-Based HLA Typing
Eplet Matching Compatibility Analysis
AI-Driven Bioinformatics
Long-Read Sequencing Technologies for HLA Typing

Chapter 6 Market Segment Analysis

Segmentation Breakdown
Global HLA Typing for Transplant Market, by Product and Service Type
Key Takeaways
Consumables
Instruments
Services
Global HLA Typing for Transplant Market, by Technology
Key Takeaways
Molecular Technologies
Nonmolecular Technologies
Global HLA Typing for Transplant Market, by Application
Key Takeaways
Solid Organ Transplant
Stem Cell Transplant
Global HLA Typing for Transplant Market, by End User
Key Takeaways
Hospitals and Transplant Centers
Diagnostic Laboratories
Research Institutions
Geographic Breakdown
Global HLA Typing for Transplant Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Chapter 7 Competitive Intelligence

Key Takeaways
Company Share Analysis
Strategic Analysis

Chapter 8 Appendix

Methodology
Abbreviations
Sources
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
BIO-RAD LABORATORIES INC.
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
OXFORD NANOPORE TECHNOLOGIES PLC.
PACBIO
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
A Few Emerging Start-ups/Market Disruptors

簡介目錄圖表

List of Tables

Summary Table : Global HLA Typing for Transplant Market, by Region, Through 2030
Table 1 : Comparison of HLA Testing Techniques
Table 2 : Comparison of HLA Systems
Table 3 : Number of Global Solid Organ Transplants, 2024
Table 4 : Estimated New Blood Cancer Cases and Deaths in the U.S., 2025
Table 5 : Global HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 6 : Global HLA Typing for Transplant Market for Consumables, by Region, Through 2030
Table 7 : Global HLA Typing for Transplant Market for Instruments, by Region, Through 2030
Table 8 : Global HLA Typing for Transplant Market for Services, by Region, Through 2030
Table 9 : Global HLA Typing for Transplant Market, by Technology, Through 2030
Table 10 : Global HLA Typing for Transplant Market for Molecular Technologies, by Region, Through 2030
Table 11 : Global HLA Typing for Transplant Market for Nonmolecular Technologies, by Region, Through 2030
Table 12 : Global HLA Typing for Transplant Market, by Application, Through 2030
Table 13 : Global HLA Typing for Transplant Market for Solid Organ Transplant, by Region, Through 2030
Table 14 : Global HLA Typing for Transplant Market for Stem Cell Transplant, by Region, Through 2030
Table 15 : Global HLA Typing for Transplant Market, by End User, Through 2030
Table 16 : Global HLA Typing for Transplant Market for Hospitals and Transplant Centers, by Region, Through 2030
Table 17 : Global HLA Typing for Transplant Market for Diagnostic Laboratories, by Region, Through 2030
Table 18 : Global HLA Typing for Transplant Market for Research Institutions, by Region, Through 2030
Table 19 : Global HLA Typing for Transplant Market, by Region, Through 2030
Table 20 : North American HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 21 : North American HLA Typing for Transplant Market, by Technology, Through 2030
Table 22 : North American HLA Typing for Transplant Market, by Application, Through 2030
Table 23 : North American HLA Typing for Transplant Market, by End User, Through 2030
Table 24 : North American HLA Typing for Transplant Market, by Country, Through 2030
Table 25 : European HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 26 : European HLA Typing for Transplant Market, by Technology, Through 2030
Table 27 : European HLA Typing for Transplant Market, by Application, Through 2030
Table 28 : European HLA Typing for Transplant Market, by End User, Through 2030
Table 29 : European HLA Typing for Transplant Market, by Country, Through 2030
Table 30 : Asia-Pacific HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 31 : Asia-Pacific HLA Typing for Transplant Market, by Technology, Through 2030
Table 32 : Asia-Pacific HLA Typing for Transplant Market, by Application, Through 2030
Table 33 : Asia-Pacific HLA Typing for Transplant Market, by End User, Through 2030
Table 34 : Asia-Pacific HLA Typing for Transplant Market, by Country, Through 2030
Table 35 : RoW HLA Typing for Transplant Market, by Product and Service Type, Through 2030
Table 36 : RoW HLA Typing for Transplant Market, by Technology, Through 2030
Table 37 : RoW HLA Typing for Transplant Market, by Application, Through 2030
Table 38 : RoW HLA Typing for Transplant Market, by End User, Through 2030
Table 39 : RoW HLA Typing for Transplant Market, by Sub-Region, Through 2030
Table 40 : Recent Developments in HLA Typing for Transplant Market, 2023-2025
Table 41 : Abbreviations Used in the Global HLA Typing for Transplant Market
Table 42 : Information Sources for this Report
Table 43 : Agilent Technologies Inc.: Company Snapshot
Table 44 : Agilent Technologies Inc.: Financial Performance, FY 2024 and 2025
Table 45 : Agilent Technologies Inc.: Product Portfolio
Table 46 : Agilent Technologies Inc.: News/Key Developments, 2024
Table 47 : BD: Company Snapshot
Table 48 : BD: Financial Performance, FY 2024 and 2025
Table 49 : BD: Product Portfolio
Table 50 : BD: News/Key Developments, 2025
Table 51 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 52 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 53 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 54 : Bio-Rad Laboratories Inc.: News/Key Developments, 2025
Table 55 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 56 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2023 and 2024
Table 57 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 58 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2024-2025
Table 59 : Illumina Inc.: Company Snapshot
Table 60 : Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 61 : Illumina Inc.: Product Portfolio
Table 62 : Illumina Inc.: News/Key Developments, 2025
Table 63 : Oxford Nanopore Technologies plc.: Company Snapshot
Table 64 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2023 and 2024
Table 65 : Oxford Nanopore Technologies plc.: Product Portfolio
Table 66 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024-2025
Table 67 : PacBio: Company Snapshot
Table 68 : PacBio: Financial Performance, FY 2023 and 2024
Table 69 : PacBio: Product Portfolio
Table 70 : PacBio: News/Key Developments, 2025
Table 71 : Qiagen: Company Snapshot
Table 72 : Qiagen: Financial Performance, FY 2023 and 2024
Table 73 : Qiagen: Product Portfolio
Table 74 : Qiagen: News/Key Developments, 2025
Table 75 : Revvity: Company Snapshot
Table 76 : Revvity: Financial Performance, FY 2023 and 2024
Table 77 : Revvity: Product Portfolio
Table 78 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 79 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 80 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 81 : Thermo Fisher Scientific Inc.: News/Key Developments, 2025
Table 82 : List of a Few Emerging Startups/Market Disruptors

List of Figures

Summary Figure : Global Market Shares of HLA Typing for Transplant, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Global HLA Typing for Transplant Market
Figure 2 : Market Dynamics of HLA Typing for Transplant Market
Figure 3 : Advantages of NGS-Based HLA Typing
Figure 4 : Global Market Shares of HLA Typing for Transplant, by Product and Service Type, 2024
Figure 5 : Global Market Shares of HLA Typing for Transplant, by Technology, 2024
Figure 6 : Global Market Shares of HLA Typing for Transplant, by Application, 2024
Figure 7 : Global Market Shares of HLA Typing for Transplant, by End User, 2024
Figure 8 : Global Market Shares of HLA Typing for Transplant, by Region, 2024
Figure 9 : North American Market Shares of HLA Typing Market for Transplant, by Country, 2024
Figure 10 : European Market Shares of HLA Typing Market for Transplant, by Country, 2024
Figure 11 : Asia-Pacific Market Shares of HLA Typing Market for Transplant, by Country, 2024
Figure 12 : RoW Market Shares of HLA Typing Market for Transplant, by Sub-region, 2024
Figure 13 : Company Shares of Market for HLA Typing for Transplant, 2024
Figure 14 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 15 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 16 : BD: Revenue Shares, by Business Unit, FY 2025
Figure 17 : BD: Revenue Shares, by Country/Region, FY 2025
Figure 18 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 19 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 20 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2024
Figure 21 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2024
Figure 22 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
Figure 23 : Oxford Nanopore Technologies plc.: Revenue Share, by Country/Region, FY 2024
Figure 24 : PacBio: Revenue Share, by Country/Region, FY 2024
Figure 25 : Qiagen: Revenue Share, by Business Unit, FY 2024
Figure 26 : Qiagen: Revenue Share, by Country/Region, FY 2024
Figure 27 : Revvity: Revenue Shares, by Business Unit, FY 2024
Figure 28 : Revvity: Revenue Shares, by Country/Region, FY 2024
Figure 29 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 30 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024